A phase 3 randomised, placebo-controlled, double-blind study of Niraparib in combination with Abiraterone acetate and Prednisone versus Abiraterone acetate and Prednisone for treatment of subjects with metastatic prostate cancer [MAGNITUDE].
- Pook, David (Primary Chief Investigator (PCI))
- Baker, Emma (Project Manager)
Project: Research